Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Why J.C. Penney, Susser Petroleum Partners, and Flamel Technologies Jumped Today

On Monday, the stock market bounced back after last week's disappointing finish, as things didn't go as badly in the geopolitical realm as some had feared. Early excitement about merger and acquisition activity in the pharmaceutical space gave way to concerns about economic sanctions on Russia, but overall, broader markets managed gains of a quarter-percent to a half-percent. Yet J.C. Penney (NYSE: JCP  ) , Susser Petroleum Partners (NYSE: SUSP  ) , and Flamel Technologies (NASDAQ: FLML  ) all managed much larger gains, with a variety of different news items lifting shareholders' spirits about the companies.

J.C. Penney gained 9% after one of its suppliers made positive comments about its success with the struggling retailer. The CEO of Izod and Tommy Hilfiger brand-owner PVH said that its business at J.C. Penney is going better than it expected, specifically highlighting its Van Heusen and Izod lines and its men's collections. If the supplier's experience is representative of J.C. Penney's overall business conditions, then it could point to favorable comparisons versus last year's debacle, and that could provide even bigger gains for shareholders going forward.

Susser Petroleum Partners soared 22% as Energy Transfer Partners (NYSE: ETP  ) announced that it would buy out the master limited partnership's general partner and its incentive distribution rights in Susser Petroleum Partners for $1.8 billion. Energy Transfer Partners said that eventually, it expects to drop down all of its combined retail businesses to Susser Petroleum Partners under ETP's Sunoco brand. Interestingly, even though Susser Petroleum Partners unitholders won't receive any compensation from today's deal, investors believe that the competitive benefit to the combination enhances Susser's value immensely.

Flamel Technologies gained 12% as investors anticipated a potentially groundbreaking announcement in the near future. Last September, the Food and Drug Administration accepted a new drug application from Flamel for review, and at the time, it set its target date to complete its review of the NDA. That so-called Prescription Drug User Fee Act or PDUFA date was today, so investors are hoping Flamel will get positive news from the FDA. Interestingly, Flamel chose not to disclose the product for which it was seeking FDA approval, citing competitive reasons. But with investors extremely interested in the pharmaceutical and biotech spaces right now, even the hope of a positive result is apparently good enough to draw interest in Flamel Technologies and its drug-delivery technology.

Will this stock be your next multi-bagger?
Give me five minutes, and I'll show how you could own the best stock for 2014. Every year, The Motley Fool's chief investment officer hand-picks one stock with outstanding potential. But it's not just any run-of-the-mill company. It's a stock perfectly positioned to cash in on one of the upcoming year's most lucrative trends. Last year, his pick skyrocketed 134%. And previous top picks have gained upwards of 908%, 1,252%, and 1,303% over the subsequent years! Believe me, you don't want to miss what could be his biggest winner yet! Just click here to download your free copy of "The Motley Fool's Top Stock for 2014" today.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2933717, ~/Articles/ArticleHandler.aspx, 9/1/2015 6:22:45 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Dan Caplinger

Dan Caplinger has been a contract writer for the Motley Fool since 2006. As the Fool's Director of Investment Planning, Dan oversees much of the personal-finance and investment-planning content published daily on With a background as an estate-planning attorney and independent financial consultant, Dan's articles are based on more than 20 years of experience from all angles of the financial world.

Today's Market

updated Moments ago Sponsored by:
DOW 16,058.35 -469.68 -2.84%
S&P 500 1,913.85 -58.33 -2.96%
NASD 4,636.11 -140.40 -2.94%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/1/2015 4:03 PM
ETP $48.39 Down -0.75 -1.53%
Energy Transfer Pa… CAPS Rating: *****
FLML $21.96 Down -0.19 -0.86%
Flamel Technologie… CAPS Rating: ***
JCP $9.26 Up +0.15 +1.65%
J.C. Penney Compan… CAPS Rating: *
SUSP $0.00 Down +0.00 +0.00%